星奕昂/NEUKIO
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Neukio Biotherapeutics completed Series A-1 financing, to accelerate discovery and development of next generation cell therapy products 2022-09-02 20:50
Neukio Biotherapeutics completed its $40m Angel round financing, focusing on the development of iPSC-CAR-NK platform and assets. 2021-07-30 08:00
1